Watch Leading Oncology Specialists Discuss The Current Lung Cancer Landscape
Chapters
1Epidemiology, Screening, and Staging of Lung Cancer2Treatment of Resectable and Unresectable Stage III NSCLC and LS-SCLC3Treatment of Metastatic NSCLC and ES-SCLCEpidemiology, Screening, and Staging of Lung Cancer
Treatment of Resectable and Unresectable Stage III NSCLC and LS-SCLC
Treatment of Metastatic NSCLC and ES-SCLC
Expert Panel
J. Jay Zhang, MD, PhD
Associate Professor
UT MD Anderson Cancer Center
Houston, Texas
Steven Lin, MD, PhD
Associate Professor
UT MD Anderson Cancer Center
Houston, Texas
Boris Sepesi, MD
Associate Professor
UT MD Anderson Cancer Center
Houston, Texas
Program Objectives
Discuss unmet needs and incorporating a multidisciplinary approach for resectable NSCLC
Review the treatment landscape for unresectable Stage III NSCLC
Review the treatment landscape for LS-SCLC
